CN115670941A - Functional suspension modeling crystal ball and manufacturing method thereof - Google Patents
Functional suspension modeling crystal ball and manufacturing method thereof Download PDFInfo
- Publication number
- CN115670941A CN115670941A CN202110838188.7A CN202110838188A CN115670941A CN 115670941 A CN115670941 A CN 115670941A CN 202110838188 A CN202110838188 A CN 202110838188A CN 115670941 A CN115670941 A CN 115670941A
- Authority
- CN
- China
- Prior art keywords
- crystal ball
- functional
- liquid
- active ingredient
- liquid layer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000013078 crystal Substances 0.000 title claims abstract description 74
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 20
- 239000000725 suspension Substances 0.000 title claims abstract description 13
- 239000007788 liquid Substances 0.000 claims abstract description 84
- 239000004480 active ingredient Substances 0.000 claims abstract description 37
- 238000000465 moulding Methods 0.000 claims abstract description 16
- 238000000034 method Methods 0.000 claims abstract description 12
- 239000000203 mixture Substances 0.000 claims description 16
- 239000002904 solvent Substances 0.000 claims description 16
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 9
- 230000005484 gravity Effects 0.000 claims description 9
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 8
- 229920002907 Guar gum Polymers 0.000 claims description 8
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 8
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 8
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 8
- 239000000665 guar gum Substances 0.000 claims description 8
- 235000010417 guar gum Nutrition 0.000 claims description 8
- 229960002154 guar gum Drugs 0.000 claims description 8
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 8
- 239000000419 plant extract Substances 0.000 claims description 8
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 7
- 229920002125 Sokalan® Polymers 0.000 claims description 7
- 239000004584 polyacrylic acid Substances 0.000 claims description 7
- -1 polydimethylsiloxane Polymers 0.000 claims description 7
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 7
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 7
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 6
- 235000010413 sodium alginate Nutrition 0.000 claims description 6
- 239000000661 sodium alginate Substances 0.000 claims description 6
- 229940005550 sodium alginate Drugs 0.000 claims description 6
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 claims description 5
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 5
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 5
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 4
- 241000221662 Sclerotinia Species 0.000 claims description 4
- 150000001298 alcohols Chemical class 0.000 claims description 4
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 4
- 239000001110 calcium chloride Substances 0.000 claims description 4
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 4
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 claims description 4
- 239000001527 calcium lactate Substances 0.000 claims description 4
- 229960002401 calcium lactate Drugs 0.000 claims description 4
- 235000011086 calcium lactate Nutrition 0.000 claims description 4
- 235000011187 glycerol Nutrition 0.000 claims description 4
- 239000001103 potassium chloride Substances 0.000 claims description 4
- 235000011164 potassium chloride Nutrition 0.000 claims description 4
- WDIHJSXYQDMJHN-UHFFFAOYSA-L barium chloride Chemical compound [Cl-].[Cl-].[Ba+2] WDIHJSXYQDMJHN-UHFFFAOYSA-L 0.000 claims description 3
- 229910001626 barium chloride Inorganic materials 0.000 claims description 3
- 108010048734 sclerotin Proteins 0.000 claims description 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 1
- 235000010443 alginic acid Nutrition 0.000 claims 1
- 239000000783 alginic acid Substances 0.000 claims 1
- 229920000615 alginic acid Polymers 0.000 claims 1
- 229960001126 alginic acid Drugs 0.000 claims 1
- 150000004781 alginic acids Chemical class 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- 230000006866 deterioration Effects 0.000 abstract description 4
- 239000000284 extract Substances 0.000 description 40
- 241000736199 Paeonia Species 0.000 description 35
- 235000006484 Paeonia officinalis Nutrition 0.000 description 35
- 210000001519 tissue Anatomy 0.000 description 25
- 210000004027 cell Anatomy 0.000 description 24
- 240000004749 Annona muricata Species 0.000 description 19
- 235000007747 Annona muricata Nutrition 0.000 description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- 230000000694 effects Effects 0.000 description 14
- 239000000469 ethanolic extract Substances 0.000 description 13
- 241000234282 Allium Species 0.000 description 12
- 239000002245 particle Substances 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 238000002360 preparation method Methods 0.000 description 10
- 239000000047 product Substances 0.000 description 9
- 238000000605 extraction Methods 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 8
- 102000004169 proteins and genes Human genes 0.000 description 8
- 239000000843 powder Substances 0.000 description 7
- 108050006400 Cyclin Proteins 0.000 description 6
- 102000009339 Proliferating Cell Nuclear Antigen Human genes 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 210000003491 skin Anatomy 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 5
- 239000002537 cosmetic Substances 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- 239000011347 resin Substances 0.000 description 5
- 229920005989 resin Polymers 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 4
- 108010035532 Collagen Proteins 0.000 description 4
- 230000003712 anti-aging effect Effects 0.000 description 4
- 239000007963 capsule composition Substances 0.000 description 4
- 229920001436 collagen Polymers 0.000 description 4
- 230000008014 freezing Effects 0.000 description 4
- 238000007710 freezing Methods 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 239000003094 microcapsule Substances 0.000 description 4
- 239000011148 porous material Substances 0.000 description 4
- 230000001681 protective effect Effects 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000006286 aqueous extract Substances 0.000 description 3
- 239000012876 carrier material Substances 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000002481 ethanol extraction Methods 0.000 description 3
- 230000008099 melanin synthesis Effects 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 230000004224 protection Effects 0.000 description 3
- 230000008439 repair process Effects 0.000 description 3
- 238000003809 water extraction Methods 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- 244000291564 Allium cepa Species 0.000 description 2
- 230000028937 DNA protection Effects 0.000 description 2
- 230000033616 DNA repair Effects 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 102000004150 Flap endonucleases Human genes 0.000 description 2
- 108090000652 Flap endonucleases Proteins 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 102000003425 Tyrosinase Human genes 0.000 description 2
- 108060008724 Tyrosinase Proteins 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 230000006837 decompression Effects 0.000 description 2
- UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- 238000004020 luminiscence type Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 201000001441 melanoma Diseases 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 229940072113 onion extract Drugs 0.000 description 2
- 231100000572 poisoning Toxicity 0.000 description 2
- 230000000607 poisoning effect Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 229960004063 propylene glycol Drugs 0.000 description 2
- 235000013772 propylene glycol Nutrition 0.000 description 2
- 239000007870 radical polymerization initiator Substances 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 239000013049 sediment Substances 0.000 description 2
- UQDJGEHQDNVPGU-UHFFFAOYSA-N serine phosphoethanolamine Chemical compound [NH3+]CCOP([O-])(=O)OCC([NH3+])C([O-])=O UQDJGEHQDNVPGU-UHFFFAOYSA-N 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000035899 viability Effects 0.000 description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 240000006162 Chenopodium quinoa Species 0.000 description 1
- 241000234276 Curculigo Species 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 240000001008 Dimocarpus longan Species 0.000 description 1
- 240000005636 Dryobalanops aromatica Species 0.000 description 1
- 102100021238 Dynamin-2 Human genes 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 235000000235 Euphoria longan Nutrition 0.000 description 1
- 101000817607 Homo sapiens Dynamin-2 Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 108010021099 Lamin Type A Proteins 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 206010063493 Premature ageing Diseases 0.000 description 1
- 208000032038 Premature aging Diseases 0.000 description 1
- 239000012083 RIPA buffer Substances 0.000 description 1
- 241001558929 Sclerotium <basidiomycota> Species 0.000 description 1
- 108010041191 Sirtuin 1 Proteins 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- VKOMHJMBOXRADX-UHFFFAOYSA-K [Cl+].[Cl-].[Ba+2].[Cl-].[Cl-] Chemical compound [Cl+].[Cl-].[Ba+2].[Cl-].[Cl-] VKOMHJMBOXRADX-UHFFFAOYSA-K 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 230000010094 cellular senescence Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000002542 deteriorative effect Effects 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 238000000751 protein extraction Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 230000037393 skin firmness Effects 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 210000003934 vacuole Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
Images
Landscapes
- Cosmetics (AREA)
Abstract
Description
技术领域technical field
本发明涉及一种悬浮晶球及其制造方法,且特别涉及一种机能性悬浮造型晶球及其制造方法。The invention relates to a suspended crystal ball and a manufacturing method thereof, in particular to a functional suspended crystal ball and a manufacturing method thereof.
背景技术Background technique
化妆品业者通常为了让消费者肉眼观察到活性成分的存在或销售噱头,会将活性成分制作成可视型剂型,如:晶球、油包水型态、或水包油型态。但现有技术的制作方法多采用微流道设备,从而导致制作成本偏高。Cosmetics manufacturers usually make active ingredients into visible dosage forms, such as crystal balls, water-in-oil, or oil-in-water, in order to allow consumers to observe the existence of active ingredients with naked eyes or as a sales gimmick. However, most of the manufacturing methods in the prior art use micro-channel devices, which leads to high manufacturing costs.
举例而言,中国台湾实用新型专利公告号M466662提出的“具有促进肌肤紧致、白皙透亮及增加肌肤弹性的胶原蛋白微脂球体结构”,其利用微流道及薄膜加压射出技术制造Lipogen胶原蛋白微脂球体。微流道技术为将通过溶有脂质的油性溶剂,利用水将出口附近的油滴向外挤出,于流道出口形成小突起,于恰当时机截断液泡,可一直连续产生大小均一的胶原蛋白微脂球体;薄膜加压射出技术则以适当孔径的滤膜来获得最佳的加压过滤压力及流速以制造大小均一的胶原蛋白微脂球体。For example, the Taiwan Utility Model Patent Publication No. M466662 proposed "a collagen microliposphere structure that promotes skin firmness, whiteness and translucence, and increases skin elasticity", which uses micro-channel and film pressurized injection technology to manufacture Lipogen collagen Proteolipospheres. Microchannel technology is to use water to squeeze out the oil droplets near the outlet through the oily solvent dissolved in lipids, forming small protrusions at the outlet of the channel, cutting off the vacuoles at the right time, and continuously producing collagen of uniform size Protein lipospheres; film pressurized injection technology uses a filter membrane with an appropriate pore size to obtain the best pressurized filtration pressure and flow rate to produce collagen lipospheres of uniform size.
又举例而言,中国台湾发明专利公开号201400556提出的“构造色材料及使用其之化妆品”,构造色材料为由带有构造色的树脂粒子构成,树脂粒子为于微小管状流道内,以一定流量注入混有含水溶性自由基聚合起始剂的水介质及自由基聚合性单体的流体,使流体温度瞬间达到预先设定的温度后,于水溶性自由基聚合起始剂的存在下,使自由基聚合性单体一部分反应,借以使均匀的树脂粒子的粒子核于微小管状流道内形成,再利用附有搅拌装置的反应釜使含有所得粒子核的聚合反应液进行聚合反应所得到的树脂粒子,树脂粒子的平均粒径处于150至400nm的范围,仄他电位的绝对值处于30至80mV的范围。For another example, the "Structural Color Material and Cosmetics Using It" proposed by Taiwan Invention Patent Publication No. 201400556, the structural color material is composed of resin particles with structural color, and the resin particles are in a tiny tubular flow channel, with a certain amount of color. The flow rate is injected into the fluid mixed with the water medium containing the water-soluble radical polymerization initiator and the radical polymerizable monomer, and after the fluid temperature reaches the preset temperature instantly, in the presence of the water-soluble radical polymerization initiator, It is obtained by reacting a part of the free radical polymerizable monomer so that the particle core of uniform resin particles is formed in the tiny tubular flow channel, and then using a reactor with a stirring device to polymerize the polymerization reaction solution containing the obtained particle core For the resin particles, the average particle diameter of the resin particles is in the range of 150 to 400 nm, and the absolute value of the zeta potential is in the range of 30 to 80 mV.
再举例而言,中国台湾实用新型专利公告号M421160提出的“制造等粒径颗粒物之装置”,其包含设有空间的基座,基座分别设有连通至空间的第一流道及第二流道,且基座设有汇集第一流道及第二流道的输出流道,输出流道为流通至空间内,输出流道设有输出口;结合于基座上的驱动件,驱动件设有滑移于空间内的推杆,且推杆设有对应第一流道及第二流道的通孔;借由驱动件驱动推杆于空间内横向滑移,使推杆的通孔依序循环对齐第一流道及第二流道,如此原料可借气体间隔后制造出等粒径的颗粒物,并用于保养品。For another example, the "device for manufacturing particles of equal particle size" proposed by Taiwan Utility Model Patent Publication No. M421160 includes a base with a space, and the base is respectively provided with a first flow channel and a second flow connected to the space. channel, and the base is provided with an output flow channel that collects the first flow channel and the second flow channel. There is a push rod sliding in the space, and the push rod is provided with through holes corresponding to the first flow channel and the second flow channel; the push rod is driven to slide laterally in the space by the driving member, so that the through holes of the push rod are sequentially Circular alignment of the first flow channel and the second flow channel, so that the raw materials can be separated by gas to produce particles of equal particle size, and used for skin care products.
因此,针对现有技术的可视型剂型化妆品所存在的问题提出改善确实为本发明所属技术领域人士积极解决的课题之一Therefore, it is indeed one of the problems that people in the technical field of the present invention actively solve for the problems existing in the visible dosage form cosmetics of the prior art.
发明内容Contents of the invention
本发明的一目的在于提出一种悬浮晶球,其可保护活性成分,以避免活性成分与环境接触造成变质。An object of the present invention is to provide a suspended crystal ball, which can protect the active ingredient and prevent the active ingredient from deteriorating due to contact with the environment.
本发明的另一目的在于提出一种悬浮晶球,其可悬浮于二液体层之间的接口,以让消费者肉眼观察到活性成分。Another object of the present invention is to provide a suspended crystal ball, which can be suspended at the interface between two liquid layers, so that consumers can observe the active ingredient with naked eyes.
本发明的再一目的在于提出一种悬浮晶球,其可与二液体混合后,迅速地随着液体分层而形成于二液体层之间的接口,以降低与环境接触的时间。Another object of the present invention is to propose a suspended crystal ball, which can be mixed with two liquids, and quickly forms an interface between the two liquid layers as the liquids are layered, so as to reduce the contact time with the environment.
本发明的又一目的在于提出一种悬浮晶球,其除了可采用微流道设备制备外,亦可选择以其它非微流道设备的方式制备,从而降低制作成本。Another object of the present invention is to provide a suspended crystal ball, which can be prepared not only by microchannel equipment but also by other non-microchannel equipment, thereby reducing the production cost.
于是,本发明提出一种机能性悬浮造型晶球,其包括:主体结构以及活性成分,活性成分为填充于主体结构内或附着于主体结构外。Therefore, the present invention proposes a functional suspension molding crystal ball, which includes: a main structure and an active ingredient, wherein the active ingredient is filled in the main structure or attached to the outside of the main structure.
较佳地,机能性悬浮造型晶球的比重为0.95至1。Preferably, the specific gravity of the functional suspended crystal ball is 0.95-1.
较佳地,主体结构含有玻尿酸钠(sodium hyaluronate)、聚丙烯酸(polyacrylicacid)、海藻酸钠(sodiumalginate)、三仙胶(xanthan gum)、小核菌胶(sclerotium gum)、羟乙基纤维素(hydroxyethyl cellulose)、及瓜尔胶(guar gum)。Preferably, the main structure contains sodium hyaluronate, polyacrylic acid, sodium alginate, xanthan gum, sclerotium gum, hydroxyethyl cellulose ( hydroxyethyl cellulose), and guar gum (guar gum).
较佳地,活性成分为植物萃取物。Preferably, the active ingredient is a plant extract.
依本发明,机能性悬浮造型晶球于一般状态下为悬浮于二液体层之间的接口。使用时,可先摇晃使机能性悬浮造型晶球与二液体层混合,再取出机能性悬浮造型晶球;之后,将机能性悬浮造型晶球与二液体静置使液体分层而再形成于二液体层之间的接口,借此降低与环境接触的时间,进而避免主体结构或活性成分变质。此外,透过活性成分填充于主体结构内或附着于主体结构外,得以保护活性成分以避免其与环境接触而变质。According to the present invention, the functional suspended shaped crystal ball is suspended in the interface between two liquid layers in normal state. When using, you can first shake the functional suspended crystal ball and the two liquid layers to mix, and then take out the functional suspended crystal ball; after that, put the functional suspended crystal ball and the two liquids to let the liquid layer and then form in The interface between the two liquid layers, thereby reducing the contact time with the environment, thereby avoiding the deterioration of the main structure or active ingredients. In addition, by filling the active ingredient in the main structure or adhering to the outside of the main structure, the active ingredient can be protected from deterioration due to contact with the environment.
另一方面,本发明提出一种机能性悬浮造型晶球的制造方法,其包括:提供模具,模具具有成型穴;将晶球组合液添加至模具的成型穴内;以及透过成型组合液使成型穴内的晶球组合液形成机能性悬浮造型晶球,而机能性悬浮造型晶球包括主体结构以及活性成分,活性成分填充于主体结构内或附着于主体结构外。On the other hand, the present invention proposes a method for manufacturing functional suspended molding crystal balls, which includes: providing a mold, the mold has a forming cavity; adding the crystal ball combination liquid into the forming cavity of the mold; The crystal ball combination liquid in the hole forms a functional suspension modeling crystal ball, and the functional suspension modeling crystal ball includes a main structure and an active ingredient, and the active ingredient is filled in the main structure or attached to the outside of the main structure.
较佳地,晶球组合液含有溶剂、玻尿酸钠、聚丙烯酸、海藻酸钠、三仙胶、小核菌胶、羟乙基纤维素、瓜尔胶、及活性成分。Preferably, the crystal ball combination liquid contains solvent, sodium hyaluronate, polyacrylic acid, sodium alginate, sanxian gum, sclerotinia, hydroxyethyl cellulose, guar gum, and active ingredients.
较佳地,依晶球组合液的总重量计,玻尿酸钠的含量为0.01至5wt%,聚丙烯酸的含量为0.5至5wt%,海藻酸钠的含量为0.5至5wt%,三仙胶的含量为0.5至5wt%,小核菌胶的含量为0.5至2wt%,羟乙基纤维素的含量为0.04至2wt%,瓜尔胶的含量为0.04至2wt%,活性成分的含量为0.05至5wt%,而溶剂的含量为补足至100wt%。Preferably, based on the total weight of the crystal ball combination liquid, the content of sodium hyaluronate is 0.01 to 5 wt%, the content of polyacrylic acid is 0.5 to 5 wt%, the content of sodium alginate is 0.5 to 5 wt%, and the content of Sanxian gum 0.5 to 5% by weight, 0.5 to 2% by weight of sclerotinia, 0.04 to 2% by weight of hydroxyethyl cellulose, 0.04 to 2% by weight of guar gum, and 0.05 to 5% by weight of active ingredient %, and the content of solvent is to make up to 100wt%.
较佳地,晶球组合液的pH值为pH4至8。Preferably, the pH value of the crystal ball combination liquid is pH4-8.
较佳地,成型组合液含有溶剂、碳酸钙(calcium carbonate)、乳酸钙(calciumlactate)、氯化钙(calcium chloride)、氯化钡(barium chloride)、及氯化钾(potassiumchloride)。Preferably, the forming composition liquid contains solvent, calcium carbonate, calcium lactate, calcium chloride, barium chloride, and potassium chloride.
较佳地,依成型组合液的总重量计,碳酸钙的含量为0.5至2wt%,乳酸钙的含量为0.5至2wt%,氯化钙的含量为0.5至2wt%,氯化钡的含量为0.5至2wt%,氯化钾的含量为0.5至2wt%,而溶剂的含量为补足至100wt%。Preferably, based on the total weight of the forming combination liquid, the content of calcium carbonate is 0.5 to 2wt%, the content of calcium lactate is 0.5 to 2wt%, the content of calcium chloride is 0.5 to 2wt%, and the content of barium chloride is 0.5 to 2wt%, the content of potassium chloride is 0.5 to 2wt%, and the content of solvent is supplemented to 100wt%.
较佳地,成型组合液的pH值为pH4至8。Preferably, the pH of the forming composition liquid is pH4-8.
较佳地,于添加晶球组合液至成型穴内之前,更可利用成型组合液润湿模具的成型穴。Preferably, before adding the crystal ball combination liquid into the forming cavity, the forming cavity of the mold can be wetted with the forming combination liquid.
再一方面,本发明提供一种组合物,其包含:第一液体层、第二液体层、以及如上所述的机能性悬浮造型晶球,第一液体层与第二液体层之间形成有接口,而机能性悬浮造型晶球悬浮于界面。In yet another aspect, the present invention provides a composition, which comprises: a first liquid layer, a second liquid layer, and the above-mentioned functional suspended crystal balls, and there is formed between the first liquid layer and the second liquid layer The interface, while the functional floating shape crystal ball is suspended on the interface.
较佳地,第一液体层含有溶剂、甘油(glycerin)、活性成分、及醇类。Preferably, the first liquid layer contains solvent, glycerin, active ingredients, and alcohols.
较佳地,第二液体层含有环戊硅氧烷(cyclopentasiloxane)、聚二甲基硅氧烷(polydimethylsiloxane)、苯丙基二甲基硅烷氧基硅酸酯(phenylpropyldimethylsiloxysilicate)、及鲸蜡硬脂基聚甲基硅氧烷(cetearyl methicone)。Preferably, the second liquid layer contains cyclopentasiloxane (cyclopentasiloxane), polydimethylsiloxane (polydimethylsiloxane), phenylpropyldimethylsiloxysilicate (phenylpropyldimethylsiloxysilicate), and cetearyl Cetearyl methicone.
较佳地,依第一液体层的总重量计,甘油的含量为5至20wt%,活性成分的含量为0.1至20wt%,醇类的含量为1至10wt%,而溶剂的含量为补足至100wt%。Preferably, based on the total weight of the first liquid layer, the content of glycerin is 5 to 20 wt%, the content of active ingredients is 0.1 to 20 wt%, the content of alcohols is 1 to 10 wt%, and the content of solvent is supplemented to 100% by weight.
较佳地,依第二液体层的总重量计,环戊硅氧烷的含量为5至40wt%,聚二甲基硅氧烷的含量为1至20wt%,苯丙基二甲基硅烷氧基硅酸酯的含量为1至20wt%,鲸蜡硬脂基聚甲基硅氧烷的含量为1至20wt%。Preferably, based on the total weight of the second liquid layer, the content of cyclopentasiloxane is 5 to 40 wt%, the content of polydimethylsiloxane is 1 to 20 wt%, phenylpropyldimethylsiloxane The content of the base silicate is 1 to 20 wt%, and the content of the cetearyl polymethicone is 1 to 20 wt%.
较佳地,第一液体层的比重为1至1.5。Preferably, the specific gravity of the first liquid layer is 1 to 1.5.
较佳地,第二液体层的比重为0.6至0.95。Preferably, the specific gravity of the second liquid layer is 0.6 to 0.95.
附图说明Description of drawings
图1为流程示意图,说明着本发明的一实施方式的制造方法。FIG. 1 is a schematic flowchart illustrating a manufacturing method according to an embodiment of the present invention.
图2为结构示意图,绘示着本发明的实施方式使用的模具。FIG. 2 is a structural schematic diagram illustrating a mold used in an embodiment of the present invention.
图3为照片图,呈现本发明的实施方式得到的机能性悬浮造型晶球。Fig. 3 is a photograph showing the functional suspended crystal ball obtained in the embodiment of the present invention.
图4为照片图,呈现本发明的实施方式得到的机能性悬浮造型晶球悬浮于二液体层之间的接口。Fig. 4 is a photograph showing the interface between two liquid layers in which the functional suspended shaped crystal ball obtained by the embodiment of the present invention is suspended.
图5为流程示意图,说明着本发明的另一实施方式的制造方法;FIG. 5 is a schematic flow diagram illustrating a manufacturing method of another embodiment of the present invention;
图6为直方图,说明AMLE对于B16F10细胞活性的影响;Figure 6 is a histogram illustrating the effect of AMLE on the activity of B16F10 cells;
图7A为照片图,说明AMLW与AMLE对于DNA的保护效果;Fig. 7A is a photographic diagram illustrating the protective effects of AMLW and AMLE on DNA;
图7B为直方图,说明AMLW与AMLE对于DNA的保护效果;Figure 7B is a histogram illustrating the protective effects of AMLW and AMLE on DNA;
图8为直方图,说明刺葱萃取物对于DNA的保护效果;Figure 8 is a histogram illustrating the protective effect of the thorny onion extract on DNA;
图9为直方图,说明刺葱萃取物对于B16F10细胞活性的影响;Fig. 9 is a histogram illustrating the effect of thorny onion extract on the activity of B16F10 cells;
图10为直方图,说明刺葱萃取物对于酪胺酸酶活性的抑制效果;Fig. 10 is a histogram illustrating the inhibitory effect of the Allium japonicus extract on tyrosinase activity;
图11为照片图,说明经PSB作用后,PCNA的表现的表现量;Fig. 11 is a photogram illustrating the performance of PCNA after being acted on by PSB;
图12为照片图,说明经PSBL作用后,细胞内Lamin A蛋白质的表现的表现量。Fig. 12 is a photo graph illustrating the expression of Lamin A protein in cells after being treated with PSBL.
具体实施方式Detailed ways
为让本发明上述及/或其它目的、功效、特征更明显易懂,下文特举较佳实施方式,作详细说明于下:In order to make the above and/or other purposes, functions, and features of the present invention more obvious and understandable, the preferred implementation modes are specifically cited below, and are described in detail below:
请参照图1,本发明的一实施方式提出一种机能性悬浮造型晶球的制造方法。如图3所示,所制得的机能性悬浮造型晶球具有主体结构及活性成分,活性成分为填充于主体结构内或附着于主体结构外,借以保护活性成分以避免与环境接触造成变质。又如图4所示,所制得的机能性悬浮造型晶球可与第一液体层与第二液体层组合成一组合物并悬浮于第一液体层与第二液体层之间形成的接口。基于第一液体层的总重量,第一液体层可含有5至20wt%的甘油、0.1至20wt%的活性成分、1至10wt%的醇类(如:丙二醇(propyleneglycol)、丁二醇(butylene glycol)、或其混合物)、及补足至100wt%的溶剂(如:水),但不以此为限;而第一液体层的比重可为1至1.5,但不以此为限。基于第二液体层的总重量,第二液体层可含有5至40wt%的环戊硅氧烷、1至20wt%的聚二甲基硅氧烷、1至20wt%的苯丙基二甲基硅烷氧基硅酸酯、及1至20wt%的鲸蜡硬脂基聚甲基硅氧烷,但不以此为限;而第二液体层的比重为0.6至0.95,但不以此为限。使用时,可先摇晃组合物使机能性悬浮造型晶球与二液体层混合,再取出机能性悬浮造型晶球;之后,将机能性悬浮造型晶球与二液体静置使二液体分层再形成第一液体层与第二液体层,且机能性悬浮造型晶球形成于此二液体层之间的接口,借此降低机能性悬浮造型晶球与环境接触的时间,进而避免主体结构或活性成分变质。涉及本实施方式的制造方法的详细步骤如下所述。Please refer to FIG. 1 , an embodiment of the present invention proposes a method for manufacturing functional suspended crystal balls. As shown in Figure 3, the prepared functional suspended crystal ball has a main structure and an active ingredient. The active ingredient is filled in the main structure or attached to the outside of the main structure to protect the active ingredient from deterioration caused by contact with the environment. As shown in FIG. 4 , the prepared functional suspended crystal balls can be combined with the first liquid layer and the second liquid layer to form a composition and suspended in the interface formed between the first liquid layer and the second liquid layer. Based on the total weight of the first liquid layer, the first liquid layer may contain 5 to 20 wt% of glycerin, 0.1 to 20 wt% of active ingredients, 1 to 10 wt% of alcohols (such as: propylene glycol (propyleneglycol), butylene glycol (butylene glycol) glycol), or a mixture thereof), and a solvent (such as water) supplemented to 100wt%, but not limited thereto; and the specific gravity of the first liquid layer may be 1 to 1.5, but not limited thereto. Based on the total weight of the second liquid layer, the second liquid layer may contain 5 to 40 wt% of cyclopentasiloxane, 1 to 20 wt% of polydimethylsiloxane, 1 to 20 wt% of phenylpropyldimethylsiloxane Siloxysilicate, and 1 to 20 wt% of cetearyl polymethicone, but not limited thereto; and the specific gravity of the second liquid layer is 0.6 to 0.95, but not limited thereto . When in use, the composition can be shaken first to mix the functional suspended crystal balls with the two liquid layers, and then the functional suspended crystal balls can be taken out; after that, the functional suspended crystal balls and the two liquids can be left to stand to make the two liquids layer again The first liquid layer and the second liquid layer are formed, and the functional suspended crystal ball is formed at the interface between the two liquid layers, thereby reducing the contact time of the functional suspended crystal ball with the environment, thereby avoiding the main structure or activity Ingredients spoiled. The detailed steps related to the manufacturing method of this embodiment are as follows.
首先,提供模具(1),模具具有成型穴(11)及二个与成型穴(11)连通的开口(步骤S11)。一般而言,成型穴(11)的外型可决定机能性悬浮造型晶球的外型。如图2所示,成型穴(11)的外型为心形时,机能性悬浮造型晶球的外型当然为心形。可理解的是,成型穴(11)的外型也可为圆形、三角形、或星形,但不以此为限。Firstly, a mold (1) is provided, and the mold has a forming cavity (11) and two openings communicating with the forming cavity (11) (step S11). Generally speaking, the shape of the forming hole (11) can determine the shape of the functional suspended molding crystal ball. As shown in Figure 2, when the external shape of the forming hole (11) is heart-shaped, the external shape of the functional suspended molding crystal ball is of course heart-shaped. It is understandable that the shape of the forming cavity (11) can also be circular, triangular, or star-shaped, but not limited thereto.
接着,将模具(1)的其中一开口置于成型组合液(3)中,使成型组合液(3)润湿模具(1)的成型穴(11)(步骤S12)。须说明的是,润湿成型穴(11)的目的在于:便于将后续得到的机能性悬浮造型晶球自成型穴(11)脱模取出而不残留于模具(1)中。基于成型组合液(3)的总重量,成型组合液(3)可含有0.5至2wt%的碳酸钙、0.5至2wt%的乳酸钙、0.5至2wt%的氯化钙、0.5至2wt%的氯化钡、0.5至2wt%的氯化钾、及补足至100wt%的溶剂(如:水),但不以此为限;而成型组合液(3)的pH值可为pH4至8,但不以此为限。Next, place one of the openings of the mold (1) in the forming composition liquid (3), and make the forming composition liquid (3) wet the forming cavity (11) of the mold (1) (step S12). It should be noted that the purpose of wetting the forming cavity (11) is to facilitate the removal of the subsequently obtained functional suspension shaped crystal balls from the forming cavity (11) without remaining in the mold (1). Based on the total weight of the forming combination liquid (3), the forming combination liquid (3) can contain 0.5 to 2wt% calcium carbonate, 0.5 to 2wt% calcium lactate, 0.5 to 2wt% calcium chloride, 0.5 to 2wt% chlorine Barium chloride, 0.5 to 2wt% potassium chloride, and a solvent (such as water) supplemented to 100wt%, but not limited thereto; and the pH value of the forming combination liquid (3) can be pH4 to 8, but not This is the limit.
最后,将晶球组合液(2)添加至模具(1)的成型穴(11)内,以透过成型穴(11)内的成型组合液(3)使晶球组合液(2)形成机能性悬浮造型晶球(4)(步骤S13、S14)。基于晶球组合液(2)的总重量,晶球组合液(2)可含有0.01至5wt%的玻尿酸钠、0.5至5wt%的聚丙烯酸、0.5至5wt%的海藻酸钠、0.5至5wt%的三仙胶、0.5至2wt%的小核菌胶、0.04至2wt%的羟乙基纤维素、0.04至2wt%的瓜尔胶、0.05至5wt%的活性成分、及补足至100wt%的溶剂(如:水),但不以此为限;而晶球组合液(2)的pH值可为pH4至8,但不以此为限。此外,活性成分可定义为具有促进皮肤保护修护、抗皱、抗氧化、抗发炎、抗老化、及美白等功效之一的成分,较佳地为植物萃取物。举例而言,植物萃取物可为中国台湾发明专利公告号I697332所述的牛樟芽胚组织萃取物、中国台湾发明专利公开号202021609所述的兰花芽胚组织萃取物、中国台湾发明专利公开号202023527所述的仙茅萃取物、中国发明专利公开号CN109276493A所述的龙眼花萃取物、或中国发明专利公开号CN108852924A所述的红藜萃取物,但不以此为限,该等文献全文并于此以供参考。须说明的是,由于成型组合液(3)可使晶球组合液(2)聚合形成包括主体结构以及活性成分的机能性悬浮造型晶球(4),故主体结构可含有玻尿酸钠、聚丙烯酸、海藻酸钠、三仙胶、小核菌胶、羟乙基纤维素、及瓜尔胶,但不以此为限。此外,机能性悬浮造型晶球(4)的比重可为0.95至1,但不以此为限。Finally, add the crystal ball combination liquid (2) into the forming cavity (11) of the mold (1), so that the forming function of the crystal ball combination liquid (2) can pass through the forming cavity (11) Suspension modeling crystal ball (4) (steps S13, S14). Based on the total weight of the crystal ball combination liquid (2), the crystal ball combination liquid (2) may contain 0.01 to 5wt% sodium hyaluronate, 0.5 to 5wt% polyacrylic acid, 0.5 to 5wt% sodium alginate, 0.5 to 5wt% Sanxian gum, 0.5 to 2wt% sclerotin, 0.04 to 2wt% hydroxyethyl cellulose, 0.04 to 2wt% guar gum, 0.05 to 5wt% active ingredient, and a solvent that is supplemented to 100wt% (such as: water), but not limited thereto; and the pH value of the crystal ball combination liquid (2) may be pH 4 to 8, but not limited thereto. In addition, an active ingredient can be defined as an ingredient that has one of the functions of promoting skin protection and repair, anti-wrinkle, anti-oxidation, anti-inflammation, anti-aging, and whitening, and is preferably a plant extract. For example, the plant extract can be the Cinnamomum camphora germ tissue extract described in Taiwan Invention Patent Publication No. I697332, the orchid germ tissue extract described in Taiwan Invention Patent Publication No. 202021609, and the Chinese Taiwan Invention Patent Publication No. 202023527. Curculigo grass extract described above, longan flower extract described in Chinese invention patent publication number CN109276493A, or red quinoa extract described in Chinese invention patent publication number CN108852924A, but not limited thereto, and the full text of these documents is hereby incorporated for reference. It should be noted that since the molding combination liquid (3) can polymerize the crystal ball combination liquid (2) to form a functional suspended crystal ball (4) including the main structure and active ingredients, the main structure can contain sodium hyaluronate, polyacrylic acid , sodium alginate, sanxian gum, sclerotinia, hydroxyethyl cellulose, and guar gum, but not limited thereto. In addition, the specific gravity of the functional suspension molding crystal ball (4) may be 0.95 to 1, but not limited thereto.
请另参照图5,本发明的另一实施方式提出一种机能性悬浮造型晶球的制造方法。若无特别叙明,本实施方式的用语所表示的意思原则上与上一实施方式的用语所表示的意思相同。涉及本实施方式的制造方法的详细步骤如下所述。Please also refer to FIG. 5 , another embodiment of the present invention proposes a method for manufacturing a functional suspended crystal ball. Unless otherwise specified, the meanings expressed by the terms of this embodiment are in principle the same as the meanings expressed by the terms of the previous embodiment. The detailed steps related to the manufacturing method of this embodiment are as follows.
首先,提供模具(1),模具具有成型穴(11)以及一个与成型穴(11)连通的开口(步骤S21)。First, a mold (1) is provided, which has a forming cavity (11) and an opening communicating with the forming cavity (11) (step S21).
接着,将晶球组合液(2)经由开口添加至模具(1)的成型穴(11)内(步骤S22)。此外,如前所述,为便于将后续得到的机能性悬浮造型晶球自成型穴(11)脱模取出而不残留于模具(1)中,于晶球组合液(2)添加前,可利用成型组合液润湿模具(1)的成型穴(11)。Next, the crystal ball combination liquid (2) is added into the forming cavity (11) of the mold (1) through the opening (step S22). In addition, as mentioned above, in order to remove the subsequently obtained functional suspended crystal balls from the forming cavity (11) without remaining in the mold (1), before adding the crystal ball combination liquid (2), you can The molding cavity (11) of the mold (1) is wetted with the molding combination liquid.
最后,添加成型组合液(3)至成型穴(11)内的晶球组合液(2)以透过成型穴(11)内的成型组合液(3)使成型穴(11)内的晶球组合液(2)形成机能性悬浮造型晶球(4)(步骤S23、S24)。Finally, add the forming combination liquid (3) to the crystal ball combination liquid (2) in the forming cavity (11) to penetrate the forming combination liquid (3) in the forming cavity (11) to make the crystal balls in the forming cavity (11) The combination solution (2) forms a functional suspended crystal ball (4) (steps S23, S24).
更佳者,该植物萃取物为山刺番荔枝叶萃取物。于一较佳实施例中,该山刺番荔枝叶萃取物的制备方法包含:首先,将山刺番荔枝叶子洗净,阴干约3至5天,再将山刺番荔枝叶子剪成小碎片约0.5cm2大小以进行萃取。其中,本发明的萃取率公式为:(萃取物重量/样品原总重)×100%。再来,将剪碎的山刺番荔枝叶进行浸泡步骤,于此步骤中包含两种实施态样,其中,第一实施态样为“超声波低温水萃法”,具体而言,其实施方式为:将山刺番荔枝叶子秤取约100g于4℃的环境下浸泡于900ml的去离子水中,并以超声波振荡萃取设备,于低温下以总能量300~600w的能量连续式萃取。于一较佳实施例中,该连续式萃取以震荡3分钟,休息2分钟的方式一共震荡60分钟。于另一较佳实施例中,于连续式萃取完成后,在4℃温度下以15,000rpm高速离心30分钟,收集上清液,再经抽真空过滤器过滤,获得澄清过滤液,利用减压浓缩机及冷冻干燥机将半成品萃取液进行浓缩,制成山刺番荔枝叶水萃取物。于又一较佳实施例中,山刺番荔枝叶水萃取物的冻干物储存于-80℃;第二实施态样为“超声波低温乙醇萃法”,具体而言,其实施方式为:将山刺番荔枝叶子秤取约100g浸泡于五倍体积的95%乙醇,于4℃的环境中避光三天,取出后于低温下以总能量300~600w的能量连续式萃取。于一较佳实施例中,该连续式萃取以震荡3分钟,休息2分钟的方式一共震荡60分钟。于另一较佳实施例中,于连续式萃取完成后,在4℃温度下以15,000rpm高速离心30分钟,收集上清液,再经抽真空过滤器过滤,获得澄清过滤液,利用减压浓缩机及冷冻干燥机将半成品萃取液进行去除溶剂作业,制成山刺番荔枝叶乙醇萃取物。于又一较佳实施例中,该山刺番荔枝叶乙醇萃取物的冻干物储存于-80℃。以下将山刺番荔枝叶水萃萃取物简称为AMLW:将山刺番荔枝叶乙醇萃萃取物简称为AMLE。More preferably, the plant extract is soursop leaf extract. In a preferred embodiment, the preparation method of the soursop leaf extract comprises: first, washing the soursop leaves, drying them in the shade for about 3 to 5 days, and then cutting the soursop leaves into small pieces About 0.5cm 2 size for extraction. Wherein, the extraction rate formula of the present invention is: (extract weight/sample original total weight)×100%. Next, soak the shredded soursop leaves. This step includes two implementations, wherein the first implementation is "ultrasonic low-temperature water extraction". Specifically, its implementation is : Weigh about 100g of soursop leaves, soak them in 900ml of deionized water at 4°C, and use ultrasonic vibration extraction equipment to continuously extract at low temperature with a total energy of 300-600w. In a preferred embodiment, the continuous extraction is shaken for 3 minutes and rested for 2 minutes for a total of 60 minutes. In another preferred embodiment, after the continuous extraction is completed, centrifuge at a high speed of 15,000 rpm for 30 minutes at a temperature of 4°C, collect the supernatant, and then filter it through a vacuum filter to obtain a clarified filtrate. The concentrator and freeze dryer concentrate the semi-finished extract to make the soursop leaf water extract. In yet another preferred embodiment, the freeze-dried product of the water extract of soursop leaves is stored at -80°C; the second embodiment is "ultrasonic low-temperature ethanol extraction method", specifically, the implementation method is: About 100g of soursop leaves were weighed and soaked in five times the volume of 95% ethanol, kept in the dark at 4°C for three days, and extracted continuously at low temperature with a total energy of 300-600w. In a preferred embodiment, the continuous extraction is shaken for 3 minutes and rested for 2 minutes for a total of 60 minutes. In another preferred embodiment, after the continuous extraction is completed, centrifuge at a high speed of 15,000 rpm for 30 minutes at a temperature of 4°C, collect the supernatant, and then filter it through a vacuum filter to obtain a clarified filtrate. The concentrator and freeze dryer will remove the solvent from the semi-finished extract to produce the ethanol extract of soursop leaves. In yet another preferred embodiment, the lyophilized product of the ethanol extract of soursop leaves is stored at -80°C. The water extract of soursop leaves is abbreviated as AMLW below: the ethanol extract of soursop leaves is abbreviated as AMLE.
如图6所示,为山刺番荔枝叶乙醇萃取物以50~1000μg/ml作用于黑色毒瘤细胞(B16F10细胞)时,B16F10细胞的存活度,其中:AMLE于50μg/ml时,即对老鼠黑色毒瘤细胞(B16F10)细胞具有显著毒性,其细胞存活度只剩下30%,表示山刺番荔枝叶乙醇萃取物具有毒杀癌细胞的作用,可用于制备治疗皮肤癌的医药品、化妆品、保养品、人体清洁用品、或香氛等产品的原料。As shown in Figure 6, it is the viability of B16F10 cells when the ethanol extract of soursop leaves acts on melanoma cells (B16F10 cells) at 50-1000 μg/ml. Black tumor cells (B16F10) cells have significant toxicity, and the cell viability is only 30%, which means that the ethanol extract of soursop leaves has the effect of poisoning and killing cancer cells, and can be used to prepare medicines, cosmetics, Raw materials for skin care products, body cleansing products, or fragrances.
如图7A至7B所示,为经过UVB照射的DNA pUC119试验,当DNA受到破坏时,DNA会从环形环绕结构(supercoiled-form,S-form)断裂成直线结构(linear-form,L-form),利用不同分子量的核酸在胶体孔径中移动速度的差异特性,将pUC19 DNA以H2O2(1mM)诱导及UVB(20mJ/cm2)照射,若DNA能受到保护作用时,则能呈现至S-form的位置,而当受到破坏时,DNA便会呈现在L-form的位置。如图7A至7B所示,可发现控制组未受到伤害可以保持完整的DNA型态并呈现环绕结构,未加药物的UVB伤害组别,DNA结构受到损伤而呈现直线形结构,而先添加AMLS或AMLW再经UVB照射的状态下,可保持较完整的DNA环绕结构,因此可发现山刺番荔枝叶萃取物具有DNA保护的作用,并且山刺番荔枝叶的水萃萃取物对于DNA的保护效果较乙醇萃萃取物为佳。As shown in Figures 7A to 7B, it is the DNA pUC119 test that has been irradiated by UVB. When the DNA is damaged, the DNA will break into a linear structure (linear-form, L-form) from a circular surrounding structure (supercoiled-form, S-form). ), using the difference in the moving speed of nucleic acids with different molecular weights in the colloidal pore size, the pUC19 DNA was induced by H 2 O 2 (1mM) and irradiated with UVB (20mJ/cm 2 ). The position of the S-form, and when damaged, the DNA will appear in the position of the L-form. As shown in Figures 7A to 7B, it can be found that the control group is not damaged and can maintain a complete DNA pattern and present a circular structure. In the UVB damage group without drugs, the DNA structure is damaged and presents a linear structure, and AMLS is added first. Or AMLW can maintain a relatively complete DNA surrounding structure when it is irradiated by UVB. Therefore, it can be found that the extract of soursop leaves has the effect of protecting DNA, and the water extract of soursop leaves has a protective effect on DNA. The effect is better than ethanol extract.
更佳者,该植物萃取物为刺葱茎萃取物。于一较佳实施例中,该刺葱茎萃取物的制备方法与该山刺番荔枝叶萃取物的制备方法相同,在此不多做赘述,其中以该“超声波低温水萃法”制成一刺葱茎水萃萃取物;以该“超声波低温乙醇萃法”制成刺葱茎乙醇萃萃取物。于另一较佳实施例中,该植物萃取物为刺葱叶萃取物。于又一较佳实施例中,该刺葱叶萃取物的制备方法与该山刺番荔枝叶萃取物的制备方法相同,在此不多做赘述,其中以该“超声波低温水萃法”制成刺葱叶水萃萃取物;以该“超声波低温乙醇萃法”制成刺葱叶乙醇萃萃取物。以下将刺葱叶水萃萃取物简称为ZLLW:将刺葱叶乙醇萃萃取物简称为ZLLE;将刺葱茎水萃萃取物简称为ZLSW:将刺葱茎乙醇萃萃取物简称为ZLSE。More preferably, the plant extract is the thorn stem extract. In a preferred embodiment, the preparation method of the thorny onion stem extract is the same as that of the soursop leaf extract, so I won’t go into details here, and the “ultrasonic low-temperature water extraction method” is used to prepare An aqueous extract of the scallion stalk; the ethanol extract of the scallion stalk is prepared by the "ultrasonic low-temperature ethanol extraction method". In another preferred embodiment, the plant extract is the leaf extract of Allium japonicus. In yet another preferred embodiment, the preparation method of the thorn leaf extract is the same as the preparation method of the soursop leaf extract, and will not be repeated here, wherein the "ultrasonic low-temperature water extraction method" is used to prepare Aqueous extract of thorny allium leaves; use the "ultrasonic low-temperature ethanol extraction method" to make thorny allium leaf ethanol extract. The thorny allium leaf water extract is abbreviated as ZLLW below: the thorny allium leaf ethanol extract is abbreviated as ZLLE;
如图8所示,为刺葱萃取物对于DNA保护效果的实验,其中:于仅受H2O2、FeSO4及UVB伤害的组别,其DNA结构受到损伤,呈现大量的直线型的结构,而经刺葱茎水萃萃取物作用的组别,能保持DNA的完整型态呈现环形缠绕结构,具有优异的DNA保护的作用。As shown in Figure 8, it is an experiment of the DNA protection effect of the extract of the thorn onion, in which: in the group that was only damaged by H2O2, FeSO4 and UVB, the DNA structure was damaged, showing a large number of linear structures, while the DNA structure was damaged by the thorn The group of onion stem water extracts can maintain the integrity of DNA and present a circular winding structure, which has an excellent DNA protection effect.
如图9所示,为刺葱萃取物以20~1000μg/ml作用于黑色毒瘤细胞(B16F10细胞)时,B16F10细胞的存活度,其中:提供控制组,其B16F10细胞活性为100%,当添加ZLLE在100μg/ml及以上的浓度作用下,B16F10细胞存活度低于80%;当添加ZLSE在250μg/ml及以上的浓度作用下,B16F10细胞存活度低于80%,显示其对B16F10细胞具有毒性。表示刺葱叶乙醇萃萃取物或刺葱茎乙醇萃萃取物具有毒杀癌细胞的作用,可用于制备治疗皮肤癌的医药品、化妆品、保养品、人体清洁用品、或香氛等产品的原料。As shown in Figure 9, it is the viability of B16F10 cells when the Allium pilaris extract acts on melanoma cells (B16F10 cells) with 20~1000 μ g/ml, wherein: provide control group, its B16F10 cell activity is 100%, when adding Under the action of ZLLE at a concentration of 100 μg/ml and above, the survival rate of B16F10 cells was lower than 80%; when ZLSE was added at a concentration of 250 μg/ml and above, the survival rate of B16F10 cells was lower than 80%, showing that it has a positive effect on B16F10 cells toxicity. Indicates that the ethanol extract of thorny onion leaves or ethanol extract of thorny onion stems has the effect of poisoning and killing cancer cells, and can be used as raw materials for the preparation of medicines, cosmetics, skin care products, body cleaning products, or fragrances for the treatment of skin cancer .
如图10所示,ZLSE、ZLLE及ZLLW明显促进酪胺酸酶能力,导致黑色素生成量增加,且其增加比率有随浓度增高而增强的趋势,故推测ZLSE、ZLLE及ZLLW具备促进黑色素生成的能力,可用于制备促进黑色素生成或强化发根的组合物,并且所制成的组合物可做为仿晒制剂、头皮养护产品、洗发精、口服制剂、食品或生发水等产品的原料。As shown in Figure 10, ZLSE, ZLLE, and ZLLW significantly promote the ability of tyrosinase, leading to an increase in melanin production, and the increase rate tends to increase with the increase in concentration, so it is speculated that ZLSE, ZLLE, and ZLLW have the ability to promote melanin production It can be used to prepare compositions for promoting melanin production or strengthening hair roots, and the prepared compositions can be used as raw materials for products such as self-tanning preparations, scalp care products, shampoos, oral preparations, food or hair tonic.
更佳者,该植物萃取物为牡丹花蕊生长点组织萃取物。于一较佳实施例中,该牡丹花蕊生长点组织萃取物包含牡丹花蕊生长点组织水萃萃取物或牡丹花蕊生长点组织乙醇萃萃取物。于另一较佳实施例中,该牡丹花蕊生长点组织水萃萃取物的制备方法包含:采取牡丹花新鲜花蕊,将牡丹花蕊组织以急速-195.79℃(77K)液态氮冷冻固化,并以冷冻研磨器研磨牡丹花蕊组织,将牡丹花蕊组织磨成粉末;提取重量比为9:1的纯水以及牡丹花蕊组织粉末,并将牡丹花蕊组织粉末浸泡于纯水中,于温度条件4℃~50℃的情况下浸泡72~120小时;将浸泡完成的牡丹花蕊组织粉末以及纯水的混合物,于温度条件-4℃~25℃的情况下,以总能量500~800w的超声波能量连续快速振荡萃取,其中,以每震动5分钟休息2分钟的方式连续震荡,直到总震荡时间达60~120分钟;于温度条件-20℃下以15,000g高速离心10分钟以去除底部沉淀物并收集上清液;将该上清液以孔径0.22~0.45μM的多微孔结构滤膜后,利用真空筛检器的程序过滤,以获得澄清过滤液;利用减压浓缩机及真空冷冻干燥机将该澄清过滤液冻干,获得牡丹花蕊生长点组织萃取物(PSB)。于又一较佳实施例中,该牡丹花蕊生长点组织乙醇萃萃取物的制备方法包含:采取牡丹花新鲜花蕊,将牡丹花蕊组织以急速-195.79℃(77K)液态氮冷冻固化,并以冷冻研磨器研磨牡丹花蕊组织,将牡丹花蕊组织磨成粉末;提取重量比为9:1的酒精溶液(含50重量%~75重量%乙醇)以及牡丹花蕊组织粉末,并将牡丹花蕊组织粉末浸泡于酒精溶液(含50重量%~75重量%乙醇)中,于温度条件4℃~50℃的情况下浸泡72~120小时;将浸泡完成的牡丹花蕊组织粉末以及酒精溶液(含50重量%~75重量%乙醇)的混合物,于温度条件-4℃~25℃的情况下,以总能量500~800w的超声波能量连续快速振荡萃取,其中,以每震动5分钟休息2分钟的方式连续震荡,直到总震荡时间达60~120分钟;于温度条件-20℃下以15,000g高速离心10分钟以去除底部沉淀物并收集上清液;将该上清液以孔径0.22-0.45μm的多微孔结构滤膜后,利用真空筛检器的程序过滤,以获得澄清过滤液;利用减压浓缩机及真空冷冻干燥机将该澄清过滤液冻干,获得牡丹花蕊生长点组织萃取物(PSB)。以下将牡丹花蕊生长点组织萃取物简称为PSB。More preferably, the plant extract is the growth point tissue extract of peony stamens. In a preferred embodiment, the extract of growing point tissue of peony stamens comprises aqueous extract of growing point tissue of peony stamens or ethanol extract of growing point tissues of peony stamens. In another preferred embodiment, the preparation method of the water-extracted extract of peony stamen growth point tissue comprises: taking fresh peony flower stamens, freezing and solidifying the peony stamen tissue with liquid nitrogen at -195.79°C (77K) rapidly, and freezing The grinder grinds the peony stamen tissue, and grinds the peony stamen tissue into powder; extracts the pure water and the peony stamen tissue powder with a weight ratio of 9:1, and soaks the peony stamen tissue powder in pure water, at a temperature of 4°C to 50 Soak for 72-120 hours at ℃; extract the mixture of soaked peony flower stamen powder and pure water under the temperature condition of -4℃~25℃, with ultrasonic energy of 500-800w for continuous and rapid extraction , in which, shake continuously for 5 minutes and rest for 2 minutes until the total shaking time reaches 60-120 minutes; centrifuge at a high speed of 15,000g for 10 minutes under the temperature condition of -20°C to remove the bottom sediment and collect the supernatant ; After the supernatant is filtered with a microporous structure membrane with a pore size of 0.22 to 0.45 μM, it is filtered by a vacuum screening device to obtain a clarified filtrate; the clarified filter is obtained by using a decompression concentrator and a vacuum freeze dryer. Liquid freeze-dried to obtain the peony stamen growing point tissue extract (PSB). In yet another preferred embodiment, the preparation method of the ethanol extract of peony stamen growth point tissue comprises: taking fresh peony flower stamens, freezing and solidifying the peony stamen tissue with liquid nitrogen at -195.79°C (77K) rapidly, and freezing The grinder grinds the peony stamen tissue, and grinds the peony stamen tissue into powder; extracts the alcohol solution (containing 50% to 75% by weight of ethanol) and the peony stamen tissue powder with a weight ratio of 9:1, and soaks the peony stamen tissue powder in In the alcohol solution (containing 50% by weight to 75% by weight of ethanol), soak for 72 to 120 hours at a temperature of 4°C to 50°C; weight % ethanol) mixture, under the temperature condition of -4 ° C ~ 25 ° C, the ultrasonic energy with a total energy of 500 ~ 800w is continuously and rapidly oscillating to extract, wherein, the mode of shaking for 5 minutes and resting for 2 minutes is continuously oscillating until The total shaking time is 60-120 minutes; centrifuge at a high speed of 15,000g for 10 minutes under the temperature condition of -20°C to remove the bottom sediment and collect the supernatant; the supernatant is made into a microporous structure with a pore size of 0.22-0.45μm After filtering the membrane, use a vacuum screener to filter to obtain a clear filtrate; use a vacuum concentrator and a vacuum freeze dryer to freeze-dry the clarified filtrate to obtain a peony stamen growth point tissue extract (PSB). Hereinafter, the peony stamen growth point tissue extract is referred to as PSB for short.
PCNA(proliferating cell nuclear antigen)是一种增殖细胞核抗原,可作为DNA钳,帮助DNA聚合酶活性(DNA pol)然后募集FEN1(Flap内切核酸酶1)以去除悬垂的5'端,是DNA修复的最后一步涉及DNA连接酶,该酶将最终的DNA链以磷酸二酯键结合在一起。有许多机制可以修复受损的双链。如图11所示,未经过UVB伤害的控制组,PCNA表现定量(1.0),而经过UVB照射后,其表现明显降低(0.2)。而经牡丹花蕊生长点组织萃取物(PSB)作用的细胞则可明显提升PCNA的表现(0.8)。显示牡丹花蕊生长点组织萃取物可有效调控修护皮肤细胞免于UV的伤害。PCNA (proliferating cell nuclear antigen) is a proliferating cell nuclear antigen that can act as a DNA clamp to help DNA polymerase activity (DNA pol) and then recruit FEN1 (Flap endonuclease 1) to remove the overhanging 5' end, which is DNA repair The final step involves DNA ligase, the enzyme that holds the final DNA strands together in phosphodiester bonds. There are a number of mechanisms to repair damaged duplexes. As shown in FIG. 11 , in the control group without UVB damage, the performance of PCNA was quantitative (1.0), but after UVB irradiation, its performance was significantly reduced (0.2). The cells treated with peony stamen growth point tissue extract (PSB) can significantly improve the expression of PCNA (0.8). It shows that the growth point tissue extract of peony stamen can effectively regulate and repair skin cells from UV damage.
更佳者,该活性成分为牡丹花蕊复合微晶囊体组合物。于一较佳实施例中,该牡丹花蕊复合微晶囊体组合物的制备方法包含:将牡丹花蕊生长点组织萃取物(PSB)与载体原料混合,使载体原料分散形成胶体复合物。具体而言,将载体原料溶解于溶剂中,利用旋转减压浓缩仪去除溶剂以形成脂质薄膜,之后加入牡丹花蕊生长点组织萃取物(PSB)至脂质薄膜使脂质分散成胶体复合物,所获得的胶体复合物即为牡丹花蕊复合微晶囊体组合物。以下将牡丹花蕊复合微晶囊体组合物简称为PSBL。More preferably, the active ingredient is the compound microcrystalline capsule composition of peony stamens. In a preferred embodiment, the preparation method of the peony stamen composite microcrystalline capsule composition comprises: mixing the peony stamen growth point tissue extract (PSB) with carrier materials, and dispersing the carrier materials to form a colloidal complex. Specifically, the carrier material is dissolved in a solvent, and the solvent is removed by a rotary decompression concentrator to form a lipid film, and then the peony stamen growth point tissue extract (PSB) is added to the lipid film to disperse the lipid into a colloidal complex , the obtained colloid complex is the peony stamen composite microcrystalline capsule composition. Hereinafter, the peony stamen compound microcrystalline capsule composition is referred to as PSBL for short.
核纤层蛋白Lamin A基因变异可损坏DNA修复功能,而令基因组变得不稳定,导致早老症。抗衰老启动机制发现Lamin A蛋白质能刺激长寿基因SIRT1,使细胞自我保护、自我更新及推迟衰老。评估包覆型牡丹花蕊微囊(PSBL)调控抗老化蛋白Lamin A的表现,进而推迟细胞衰老。人类皮肤角质株化细胞(HaCaT细胞)(1.5×105cell/mL)培养于直径10cm的培养皿(dish),在37℃及5%CO2培养箱中培养至少24小时,加入包覆型牡丹花蕊微囊(PSBL),置入培养箱作用24小时。当达反应时间,利用RIPA buffer进行蛋白质萃取,之后进行SDS-PAGE电泳直到目标蛋白分离。加入0.5%脱脂牛奶2分钟后,再加入1级抗体反应10分钟,以0.1%磷酸盐缓冲生理盐水(PBST)冲洗3次,再加入2级抗体反应10分钟,再以0.1%PBST冲洗3次。最后加入ECL冷光感应试剂,置入冷光照相系统拍照并使用image J定量分析蛋白质表现。如图12所示,人类皮肤角质株化细胞(HaCaT细胞)经包覆型牡丹花蕊微囊(PSBL)作用后,分析细胞内Lamin A蛋白质表现量。细胞骨架蛋白β-actin作为定量控制组。结果显示,与控制组(Lamin A表现为1.0)相比,细胞经包覆型牡丹花蕊微囊(PSBL)作用后Lamin A表现增加至3.8,显示包覆型牡丹花蕊微囊(PSBL)可活化Lamin A蛋白质,推测其具抗老化效果。Mutations in the lamin A gene can impair DNA repair function and destabilize the genome, leading to premature aging. The anti-aging mechanism found that Lamin A protein can stimulate the longevity gene SIRT1, so that cells can self-protect, self-renew and delay aging. To evaluate the performance of coated peony stamen microcapsules (PSBL) to regulate the expression of anti-aging protein Lamin A, thereby delaying cellular senescence. Human skin keratinized cells (HaCaT cells) (1.5×105cell/mL) were cultured in a 10cm-diameter dish (dish), cultured in a 37°C and 5% CO2 incubator for at least 24 hours, and added coated peony flower capsule (PSBL), placed in an incubator for 24 hours. When the reaction time is up, use RIPA buffer for protein extraction, and then perform SDS-PAGE electrophoresis until the target protein is separated. Add 0.5% skimmed milk for 2 minutes, then add
惟以上所述者,仅为本发明的较佳实施例,但不能以此限定本发明的专利保护范围;故,凡依本发明的专利保护范围及发明说明书内容所作的简单的等效改变与修饰,皆仍落入本发明的专利保护范围内。But the above-mentioned person is only the preferred embodiment of the present invention, but can not limit the patent protection scope of the present invention with this; Modifications still fall within the scope of patent protection of the present invention.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110838188.7A CN115670941B (en) | 2021-07-23 | 2021-07-23 | Functional suspended crystal ball and its manufacturing method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110838188.7A CN115670941B (en) | 2021-07-23 | 2021-07-23 | Functional suspended crystal ball and its manufacturing method |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115670941A true CN115670941A (en) | 2023-02-03 |
CN115670941B CN115670941B (en) | 2025-04-04 |
Family
ID=85044171
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110838188.7A Active CN115670941B (en) | 2021-07-23 | 2021-07-23 | Functional suspended crystal ball and its manufacturing method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115670941B (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200413023A (en) * | 2002-10-16 | 2004-08-01 | Suwelack Skin & Health Care Ag | Use of shaped articles for external application |
CN106456530A (en) * | 2014-05-16 | 2017-02-22 | 雷斯托尔西有限公司 | Biphasic cosmetic |
KR20180121251A (en) * | 2017-04-28 | 2018-11-07 | 주식회사 삼양사 | Multi-layered Cosmetic Composition |
-
2021
- 2021-07-23 CN CN202110838188.7A patent/CN115670941B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200413023A (en) * | 2002-10-16 | 2004-08-01 | Suwelack Skin & Health Care Ag | Use of shaped articles for external application |
CN106456530A (en) * | 2014-05-16 | 2017-02-22 | 雷斯托尔西有限公司 | Biphasic cosmetic |
KR20180121251A (en) * | 2017-04-28 | 2018-11-07 | 주식회사 삼양사 | Multi-layered Cosmetic Composition |
Non-Patent Citations (1)
Title |
---|
王秀娟等: "海藻酸钠凝胶特性的研究", 食品工业科技, vol. 29, no. 2, pages 259 - 262 * |
Also Published As
Publication number | Publication date |
---|---|
CN115670941B (en) | 2025-04-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102265811B1 (en) | Method for isolation and purification of Centella asiatica exosome and cosmetic composition containing the same | |
CN1255095C (en) | Cosmetic preparation of active substances with synergistically increased radical protection factor | |
TW505508B (en) | Uses of oil bodies | |
CN1154474C (en) | Cosmetic preparation of active substrances with high protection factor against free radicals | |
KR20080096411A (en) | Cosmetic preparation and method for preparing the same | |
KR102329247B1 (en) | Method for isolation and purification of Portulaca oleracea exosome and cosmetic composition containing the same | |
KR102625288B1 (en) | Anti-aging, antioxidant cosmetic composition comprising broccoli exosome as an active ingredient, and functional cosmetic comprising the same | |
KR102450862B1 (en) | Cosmetic composition containing Cnidium officinale exosome, Paeonia lactiflora exosome | |
CN106994135A (en) | Sea grape extract with function of inhibiting allergy, preparation method and application | |
KR20140101570A (en) | Cosmetic composition for reinforcing skin barrier containing Persicaria hydropiper L. extract, and the liposome for enhancing transdermal delivery of Persicaria hydropiper L. extract | |
KR102008870B1 (en) | Cosmetic composition comprising micro algae extracts stabilized in algaesome as active ingredient | |
KR101797285B1 (en) | Natural liposome, process for the preparation thereof, and cosmetic composition comprising the same | |
KR20050058635A (en) | Camellia japonica extract having anti-inflammatory and anti-oxidative activities, and cosmetic composition comprising the same | |
KR101724146B1 (en) | Cosmetic composition for removal the dead skin cell containing crude drug extracts | |
KR102157210B1 (en) | The functional cosmetic composition comprising extract of natural micro organism-fermented black ginseng | |
CN115670941A (en) | Functional suspension modeling crystal ball and manufacturing method thereof | |
CN105147575A (en) | Hair restorer containing stem cells and preparation method thereof | |
KR101857282B1 (en) | Cosmetic composition comprising the extract of ishige okamurae | |
KR102140185B1 (en) | Hydrogel nanoparticles comprising hair growth solution of fermentation extract with natural products, method for manufacturing the same | |
CN116694721A (en) | Ganoderma lucidum glycopeptide and preparation method and application thereof, and ganoderma lucidum glycopeptide microemulsion and face cream | |
CN107174536A (en) | A kind of salamander face beautifying skin protection product and preparation method thereof | |
KR101825358B1 (en) | Method of producing a cosmetic sulfur additive | |
KR102253702B1 (en) | Cosmetic composition comprising seaweed ingredients and seawater | |
JP3839390B2 (en) | Cosmetics | |
RU2351376C1 (en) | Cosmetic mask |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant |